Daniel Steinfort (@dansteinfort) 's Twitter Profile
Daniel Steinfort

@dansteinfort

ID: 616969673

calendar_today24-06-2012 09:52:01

15 Tweet

64 Takipçi

71 Takip Edilen

Tajalli Saghaie (@tsaghaie) 's Twitter Profile Photo

New bronchoscopic treatment for Chronic Bronchitis; proud to have been involved in the first in human case in the world ATS Blue Journal Macquarie University @mqhealth atsjournals.org/doi/abs/10.116…

Andrew Leigh (@aleighmp) 's Twitter Profile Photo

JobKeeper was designed to reduce inequality. But some firms are using taxpayer money to pay massive executive bonuses. In 90 seconds, I listed the worst offenders andrewleigh.com/executive_sala… #auspol #ausecon Ownership Matters

Daniel Steinfort (@dansteinfort) 's Twitter Profile Photo

General social distancing measures enacted for control of the #SARSCoV2 pandemic have achieved a profound reduction in incidence of #influenza in Australia bit.ly/3hXjOkl

Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

Biniam Kidane Gerry Hanna Drew Moghanaki CTSurgSocMedNetwork Brendon Stiles Alex Louie MD, PhD 3) Currently Daniel Steinfort looking at this question of comprehensive EBUS in LA-NSCLC with the SIESMIC study. Back to the original Q, I was thinking surgery more optimal from a local control perspective!!!

Alex Louie MD, PhD (@dralexlouie) 's Twitter Profile Photo

Shankar Siva Biniam Kidane Gerry Hanna Drew Moghanaki CTSurgSocMedNetwork Brendon Stiles Daniel Steinfort Really looking forward to the SEISMIC data - EBUS will be a crucial tool in optimizing therapeutic ratio. Factors influencing - rates of up/downstaging 1. Prevalence of false positives 2. Comprehensiveness of EBUS 3. Tumor factors. Anything else?

Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

1/ Thank you 🙏🏾, patients, families, and investigators, for contributing to the SEISMIC 🫁trial out now The Lancet Respiratory Medicine - shorturl.at/qxMUY. Led by 🫁Daniel Steinfort, this international multicentre recruited n=155 trial from 🇦🇺, 🇨🇦, 🇺🇸, 🇳🇱 #radonc CTSurgSocMedNetwork Peter Mac Radiation Oncology

1/ Thank you 🙏🏾, patients, families, and investigators, for contributing to the SEISMIC 🫁trial out now <a href="/LancetRespirMed/">The Lancet Respiratory Medicine</a> - shorturl.at/qxMUY. Led by 🫁<a href="/DanSteinfort/">Daniel Steinfort</a>, this international multicentre recruited n=155 trial from 🇦🇺, 🇨🇦, 🇺🇸, 🇳🇱 #radonc <a href="/tssmn/">CTSurgSocMedNetwork</a> <a href="/PeterMacRadOnc/">Peter Mac Radiation Oncology</a>
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

2/ EBUS biopsy is usually only single station to confirm diagnosis. With clinical N2 disease, #radonc rely largely on PET avidity to define ☢️#radiotherapy fields. SEISMIC investigated systematic EBUS nodal staging in patients with locally advanced #lungcancer undergoing #radonc

2/ EBUS biopsy is usually only single station to confirm diagnosis. With clinical N2 disease, #radonc rely largely on PET avidity to define ☢️#radiotherapy fields. SEISMIC investigated systematic EBUS nodal staging in patients with locally advanced #lungcancer undergoing #radonc
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

3/ n=155, in 37% PET/EBUS was discordant – 12% ⬆️ disease, 25% ⬇️ disease extent. When upstaged with EBUS, missed lymph nodes get only ~10% of prescribed dose. We suggest use of systematic EBUS routinely before #radiotherapy. thelancet.com/journals/lanre…

Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

4/ Some rapid, more easily digestible graphics of our The Lancet Respiratory Medicine paper shorturl.at/pADQ9 and key outcomes below! #lcsm #oncology OncoAlert Targeting Cancer The Royal Melbourne Hospital #radonc. Thank you everyone 🙏🏾🙏🏾🙏🏾 and interested in thoughts!!!

4/ Some rapid, more easily digestible graphics of our <a href="/LancetRespirMed/">The Lancet Respiratory Medicine</a> paper shorturl.at/pADQ9 and key outcomes below! #lcsm #oncology <a href="/OncoAlert/">OncoAlert</a> <a href="/TargetingCancer/">Targeting Cancer</a> <a href="/TheRMH/">The Royal Melbourne Hospital</a> #radonc. Thank you everyone 🙏🏾🙏🏾🙏🏾 and interested in thoughts!!!
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

Hi 🫁#LCSM peeps! A quick interview with the The Lancet podcast team gives some more insight into the SEISMIC 🫨trial outcomes ➡️ 🔊Listen here: tinyurl.com/ynkkj39y #radonc #lungcancer